Clinical Trial Update: A Comparison of Sertraline-reboxetine Combination Therapy Versus Sertraline or Reboxetine Monotherapy in the Treatment of Major Depression. [Phase 2]

View source ↗

Summary

Phase 2 trial comparing sertraline-reboxetine combination to sertraline or reboxetine monotherapy for major depressive disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Reboxetine (Reboxetine)
• Sertraline (Sertraline)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Depressive Disorder, Major | Phase 2 | Status: COMPLETED